Vertex Pharmaceuticals Incorporated Investors: [email protected] Susie Lisa, CFA: +1 617-341-6108 or Miroslava Minkova: +1 617-341-6135 Media: [email protected] or International: +44 20 3204 ...
Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved the company’s non-opioid pain treatment. It’s the first new class ...
The Federal Drug Administration last month approved Journavx, a new kind of non-addictive pain medication. Doctors say ...
Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...
One of the most significant news items involving Vertex isn't reflected in the company's numbers just yet. Vertex's ...
In a Jan. 30 investor note, Leerink Partners analysts called Journavx’s approval “the start of something big,” and predicted that Vertex will “serially innovate and launch additional non-opioid pain ...
Granted permanent U.S. residence, as demonstrated by the issuance of a permanent residence card, i.e., a "Green Card" Granted U.S. citizenship Granted status as a "protected person" under 8 U.S.C.
That includes mobility and range of motion for shooting, passing and arm angles. Morant's return will help stabilize the Grizzlies' backcourt. Shooting guard Desmond Bane is out for Monday's game ...
The devil works hard, but Kardashian's double-sided fashion tape worked harder for her latest daring red carpet moment — all about her look Erin Clack is a Staff Editor for PEOPLE. She has been ...
They will if the generic drug is an opioid that carries the potential for addiction and the new medicine is a non-opioid that poses no such known risk. That’s the opinion of top Vertex ...
US Federal officials have approved a new pain pill by Vertex Pharmaceuticals called Journavx, aimed at reducing addiction and overdose risks associated with opioids. The drug, which works by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback